--Insmed Leads Science Top Employers
List for Second Year in a Row--
BRIDGEWATER, N.J., Oct. 27,
2022 /PRNewswire/ -- Insmed Incorporated (Nasdaq:
INSM), a global biopharmaceutical company on a mission to transform
the lives of patients with serious and rare diseases, today
announced that it has earned the highest ranking in
Science's 2022 Top Employers Survey. The annual survey polls
employees in biotechnology, pharmaceutical, and related industries
to determine the 20 best employers, as well as their driving
characteristics.
"Receiving the top spot in Science's annual survey for
two years in a row is a tremendous honor," said Will Lewis, Chair and Chief Executive Officer of
Insmed. "This recognition is a testament to the culture we have
built, as well as the importance that we place on science and
research. As we strive to achieve our ambitious goals for the
future, I am grateful to our employees around the world for their
passion, creativity, and dedication to patients."
The 2022 survey results were based on more than 6,200 responses
from individuals across North
America (63%), Europe
(15%), Asia/Pacific Rim (17%), and
other locations (5%). The highest-ranking companies on this year's
list stood out in the areas of innovative leadership, respect for
employees, and social responsibility. Following Insmed, the top
five companies this year included Alnylam, Regeneron, Incyte, and
Syngenta Group.
"In today's hyper-competitive employment market, the demand for
top talent is greater than ever," said Nicole Schaeffer, Chief People Strategy Officer
of Insmed. "I am proud that our continued focus on fostering a
collaborative, inclusive, and values-driven culture sets us apart
as a company where the brightest minds choose to spend their
careers."
"It is an honor to work alongside our immensely talented
Research team," said Eugene
Sullivan, M.D., Chief Product Strategy Officer of Insmed.
"Today, we are pursuing some of the most innovative and
cutting-edge technologies in the field of biopharmaceutical
research, and I have never been more excited about where we are
headed."
The complete feature and company rankings can be accessed here.
To learn more about Insmed's culture and explore opportunities to
join our team, please visit
https://insmed.com/culture/careers/.
About Insmed
Insmed Incorporated is a global biopharmaceutical company on a
mission to transform the lives of patients with serious and rare
diseases. Insmed's first commercial product is a first-in-disease
therapy approved in the United
States, Europe, and
Japan to treat a chronic,
debilitating lung disease. The Company is also progressing a robust
pipeline of investigational therapies targeting areas of serious
unmet need, including neutrophil-mediated inflammatory diseases and
rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a footprint
across Europe and in Japan. For more information, visit
www.insmed.com.
Contact:
Investors:
Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com
Media:
Mandy Fahey
Executive Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/insmed-ranks-no-1-on-sciences-2022-top-biopharma-employers-list-301661784.html
SOURCE Insmed Incorporated